큐리진

kor kor

큐리진 큐리진

kor kor
Pipelines

Viral delivery system

  • Research
  • Production
  • Pre-clinical
  • Clinical trials

Candidate

  • Target validation
  • product optimization
  • POC
  • in vivo efficacy
  • Process development
  • GMP production
  • GLP-tox
  • IND
  • phase 1
CA102
  • oncolytic virus
  • adenovirus

[ Target Gene : mTOR & Stat3 ]

▪Bladder Cancer

▪Head & Neck Cancer

▪Pancreatic Cancer

CA103
  • oncolytic virus
  • adenovirus

[ Target Gene : AR & mTOR ]

▪Castration-resistant prostate cancer

CA102-t
  • oncolytic virus
  • adenovirus

[ Target Gene : mTOR & Stat3 ]

[ Systemic injectable virus ]

▪Metastatic Cancer

CA104
  • oncolytic virus
  • adenovirus

[ Target Gene : c-MET & PD-L1 ]

▪Lung Cancer

▪Sold tumor

CA201
  • oncolytic virus
  • adenovirus

[ Target Gene : BCL2 & BI-1 ]

▪Renal cell carcinoma

CHS101
  • oncolytic virus
  • HSV

[ Target Gene : TBD ]

▪Melanoma

▪Squamous Cell Carcinoma of Skin

CHX101
  • non-oncolytic virus
  • adenovirus

[ Target Gene : TBD ]

· Liver disease

CA102

GLP-tox

  • oncolytic virus
  • adenovirus
  • [ Target Gene : mTOR & Stat3 ]
  • ▪Bladder Cancer
  • ▪Head & Neck Cancer
  • ▪Pancreatic Cancer
CA103

in vivo efficacy

  • oncolytic virus
  • adenovirus
  • [ Target Gene : AR & mTOR ]
  • ▪Castration-resistant prostate cancer
CA102-t

Process development

  • oncolytic virus
  • adenovirus
  • [ Target Gene : mTOR & Stat3 ]
  • [ Systemic injectable virus ]
  • ▪Metastatic Cancer
CA104

product optimization

  • oncolytic virus
  • adenovirus
  • [ Target Gene : c-MET & PD-L1 ]
  • ▪Lung Cancer
  • ▪Sold tumor
CA201

product optimization

  • oncolytic virus
  • adenovirus
  • [ Target Gene : BCL2 & BI-1 ]
  • ▪Renal cell carcinoma
CHS101

product optimization

  • oncolytic virus
  • HSV
  • [ Target Gene : TBD ]
  • ▪Melanoma
  • ▪Squamous Cell Carcinoma of Skin
CHX101

Target validation

  • non-oncolytic virus
  • adenovirus
  • [ Target Gene : TBD ]
  • · Liver disease

Non-viral delivery system

  • Research
  • Production
  • Pre-clinical
  • Clinical trials

Candidate

  • Target validation
  • product optimization
  • POC
  • in vivo efficacy
  • Process development
  • GMP production
  • GLP-tox
  • IND
  • phase 1
CS001
  • bs-siRNA
  • Naked siRNA

[ Target Gene : TBD ]

▪Glaucoma

▪Dry eye disease

CS002
  • bs-siRNA
  • AptamerConjugation

[ Target Gene : TBD ]

▪Hepatitis B virus infection

CS003
  • bs-siRNA
  • Lipid nanoparticle

[ Target Gene : TBD ]

▪Acute Kidney Injury

CS001

POC

  • bs-siRNA
  • Naked siRNA
  • [ Target Gene : TBD ]
  • ▪Glaucoma
  • ▪Dry eye disease
CS002

POC

  • bs-siRNA
  • AptamerConjugation
  • [ Target Gene : TBD ]
  • ▪Hepatitis B virus infection
CS003

POC

  • bs-siRNA
  • Lipid nanoparticle
  • [ Target Gene : TBD ]
  • ▪Acute Kidney Injury